Christian Hansen
CIK 1360573 · last filed 2010-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SUPG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DK-1100
DENMARK, G7 G7
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astex Pharmaceuticals, Inc (SUPG) Delisted | 10%+ Owner | 6,405,216 | — | — | -$696.0K | 5 | 2010-04-26 |
| QLTI | 10%+ Owner | 7,687,984 | $27.32 | $210.02M | $4.76M | 4 | 2010-03-18 |
Recent Filings · Page 2 of 2
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-04-02 | QLTI | Buy (P) | +1,258,884 | $2.22M | EDGAR |
| 2009-03-23 | QLTI | Buy (P) | +33,579 | $56.9K | EDGAR |
| 2008-04-18 | — | Mixed | +3,030,304 | $0 | |
| 2007-08-24 | — | Buy (P) | +14,400 | $16.3K | |
| 2007-06-15 | — | Buy (P) | +24,500 | $29.4K | |
| 2007-06-14 | — | Buy (P) | +20,000 | $23.9K | |
| 2007-06-13 | — | Grant (A) | +30,000 | $34.5K | |
| 2007-06-08 | — | Grant (A) | +2,500,000 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.